CIK 0001439222
- Large accelerated filer
AGIOS PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- AGIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-649-8600
- Business address
- 88 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- AGIOS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $371,112
- in 2 filings, $371K under 10b5-1 plans
Net −$371,112. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-06-11 | Biller Scott Chief Scientific Officer | Option exercise | +7,218 | $2.34 | $17K | 33,729 |
| 2019-06-11 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −7,218 | 0 | ||
| 2019-04-05 | Biller Scott Chief Scientific Officer | Option exercise | +3,000 | $39.76 | $119K | 29,511 |
| 2019-04-05 | Biller Scott Chief Scientific Officer | Sale | −2,401 | $67.61 | $162K | 27,110 |
| 2019-04-05 | Biller Scott Chief Scientific Officer | Sale | −599 | $68.12 | $41K | 26,511 |
| 2019-04-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,000 | 39,648 | ||
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise | +428 | $31.64 | $14K | 26,939 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise | +2,572 | $39.76 | $102K | 29,511 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Sale | −200 | $66.45 | $13K | 29,311 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Sale | −2,600 | $67.73 | $176K | 26,711 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Sale | −200 | $68.22 | $14K | 26,511 |
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −428 | 11,354 | ||
| 2019-03-05 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −2,572 | 42,648 | ||
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise | +1,766 | $0.47 | $830 | 28,277 |
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise | +4,154 | $9.05 | $38K | 32,431 |
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise | +3,080 | $31.64 | $97K | 35,511 |
| 2019-02-27 | Biller Scott Chief Scientific Officer | Sale | −9,000 | $65.00 | $585K | 26,511 |
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −1,766 | 0 | ||
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −4,154 | 0 | ||
| 2019-02-27 | Biller Scott Chief Scientific Officer | Option exercise · Stock option (right to buy) | −3,080 | 11,782 |
Page 1 of 9 · 165 trades